Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06380517 · ClinicalTrials.gov registry record · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
A Phase 3 study of Amblyopia, sponsored by Jaeb Center for Health Research.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 238
- Enrollment target
- 20
- Study locations
NCT06380517 is a Phase 3 study of Amblyopia that is actively recruiting participants, run by Jaeb Center for Health Research. The registered enrollment target is 238 participants, above the 156-participant average among 24 other Amblyopia trials with a reported enrollment target (53% higher). The trial reports 20 study locations across 8 states.
The verdict
NCT06380517, a Phase 3 study of Amblyopia, is actively recruiting participants, sponsored by Jaeb Center for Health Research.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 238 participants
- Enrollment target
- 20
- Study locations
Study Summary
In children 4 to 7 years of age, to determine if treatment with 1 hour per day 6 days per week of watching dichoptic movies/shows wearing the Luminopia headset is non-inferior to treatment with 2 hours of patching per day 7 days per week with respect to change in amblyopic eye distance VA from randomization to 26 weeks.
Conditions Studied
Interventions
- DEVICE Luminopia
- OTHER Eye Patch
Study Locations (20)
California
- Univ. of California- Berkeley - Berkeley
- Southern California College of Optometry - Fullerton
- Univ of California, Irvine- Gavin Herbert Eye Institute - Irvine
- Children's Hospital of Los Angeles (CHLA) - Los Angeles
- Jules Stein Eye Institute at the University of California, Los Angeles - Los Angeles
- Stanford University - Palo Alto
- Western University College of Optometry - Pomona
- University of California, Davis - Sacramento
- Rady Children's Hospital - San Diego Dept of Ophthalmology - San Diego
- University of California San Francisco Department of Ophthalmology - San Francisco
Arizona
- Midwestern University Eye Institute - Glendale
- Phoenix Children's Medical Group - Ophthalmology - Scottsdale
- University of Arizona - Tucson
Arkansas
- Arkansas Childrens - Little Rock
- McFarland Eye Care Center - Little Rock
Alabama
- UAB Pediatric Eye Care; Birmingham Health Care - Birmingham
Connecticut
- Yale University - New Haven
Florida
- University of South Florida (USF) Eye - Tampa
Georgia
- The Emory Eye Center - Atlanta
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2028-01-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06380517
The ClinicalTrials.gov registry entry for NCT06380517 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 156-participant average among 24 other Amblyopia trials with a reported enrollment target (53% higher). The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 2 interventions - of which Luminopia is the first listed.
NCT06380517 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Arizona, Arkansas.
Frequently Asked Questions
What is clinical trial NCT06380517 about?
NCT06380517 is a clinical study titled "Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age". In children 4 to 7 years of age, to determine if treatment with 1 hour per day 6 days per week of watching dichoptic movies/shows wearing the Luminopia headset is non-inferior to treatment with 2 hours of patching per day 7 days per week with respect to change in amblyopic eye distance VA from rando...
What is the current status of trial NCT06380517?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 238 participants. The study started on 2024-07-01. Estimated completion is 2028-01-01.
What conditions does trial NCT06380517 study?
This clinical trial studies the following conditions: Amblyopia.
What interventions are being tested in trial NCT06380517?
The interventions under investigation include: Luminopia (DEVICE), Eye Patch (OTHER).
Who is sponsoring clinical trial NCT06380517?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06380517 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amblyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
RECRUITING · Phase 3
-
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
RECRUITING · Phase 3
-
Amblyopia (Lazy Eye) Treatment Study
COMPLETED · Phase 3
-
Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children
COMPLETED · Phase 3
-
Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years Old
COMPLETED · Phase 3
-
Trial Comparing Part-time Versus Full-time Patching for Severe Amblyopia
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.